| abstract |
The present invention is provided to prevention or the pharmaceutical composition for the treatment of hyperlipemia, it comprises (the 4S as active component, 5R) 5 [3,5 pairs of (trifluoromethyl) phenyl] 3 ({ 2 [4 fluorine 2 methoxyl group 5 (propane 2 base) phenyl] 5 (trifluoromethyl) phenyl } methyl) 4 methyl 1,3 oxazolidine 2 ketone or its pharmaceutically acceptable salts；And calcium channel blocker or fibrates. |